Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
biotech
4
×
boston blog main
boston top stories
4
×
boulder/denver blog main
boulder/denver top stories
crispr
4
×
detroit blog main
detroit top stories
eli lilly
4
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
fda
glaxosmithkline
indiana blog main
indiana top stories
ipo
startups
abbvie
alzheimer's disease
cancer immunotherapy
clinical trials
deals
editas medicine
What
bio
roundup
companies
life
moves
new
science
week
approval
bails
big
biogen’s
biopharmaceutical
black
bosley's
bosley’s
brand
bridge
bridgebio
bucks
capital
car
cas
ceo
continue
convo
crime
crispr
debut
departure
develop
diamond
diamond’s
drug
drugs
earlier
editas
emerges
exit
failures
Language
unset
Current search:
crispr
×
biotech
×
photo
×
" boston top stories "
×
" new york top stories "
×
" eli lilly "
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More